You are here: Industry Insights > ZyCoV-D

News List

ZyCoV-D to be used in seven states initially expresspharma
December 03, 2021
The seven states are Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar Pradesh and West Bengal
Zydus Cadila likely to launch Covid-19 vaccine ZyCoV-D next month Ref: Business Standard FirstWordPharma
November 26, 2021
India's fourth COVID-19 vaccine is likely to be available next month as sources say Cadila Healthcare's ZyCoV-D, the world’s first plasmid DNA vaccine, will be launched in December, reported Business Standard.
Centre places purchase order for one crore doses of Zydus Cadila’s needle-free COVID vaccine ExpressPharma
November 09, 2021
Zydus Cadila’s three-dose COVID vaccine ZyCoV-D is set to be included in the national anti-coronavirus inoculation programme this month with the Centre placing a purchase order...
ZyCoV-D may find favour in 12-18 age group for COVID-19 vaccination in India: GlobalData expresspharma
July 02, 2021
ZyCoV-D’s Phase III interim analysis has shown efficacy of 66.6 per cent and was conducted in over 28,000 subjects, including 1000 subjects in the 12-18 age group.
Zydus applies to DCGI for EUA to launch ZyCoV-D expresspharma
July 02, 2021
The COVID-19 vaccine has been tested in adolescent population in the 12-18 years age group in India as well.
Cadila Healthcare to make around 30 million doses of COVID-19 vaccine a month: Managing Director expresspharma
May 25, 2021
Cadila Healthcare is aiming to triple the monthly production of COVID-19 vaccine candidate to as many as 30 million doses, its MD said.
Cadila Healthcare initiates production of ZyCoV-D expresspharma
April 25, 2021
Cadila Healthcare has started producing its potential COVID-19 vaccine for which it will seek emergency use authorisation in May or June, its managing director told Reuters, with an aim to make up to 240 million doses a year.
Covishield to dominate overall COVID-19 vaccination drive in India: GlobalData expresspharma
January 18, 2021
SII has taken the lead in supplying orders for the Indian government through 11 million doses ordered of Covishield versus 5.5 million doses of Covaxin.
Zydus Cadila gets DCGI approval for Phase Ill trial of ZyCoV-D expresspharma
January 04, 2021
The company will now be initiating Phase III clinical trial in around 30,000 volunteer.
Zydus seeks approval for Phase III clinical trials of ZyCoV-D, submits Phase I/II clinical trial data expresspharma
December 28, 2020
ZyCoV-D was found to be safe, well tolerated and immunogenic in the Phase I/II clinical trials, informs company.

Previous page 1 2 Next page